Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Email

Connecting Patient Populations to Clinical Trials (CP2CT)

The Connecting Patient Populations to Clinical Trials (CP2CT) program will implement and evaluate multilevel and tailored outreach and education interventions with the primary goal of increasing referral and ultimately, accrual of patient populations, to NCI-supported clinical trials (CTs) (National Clinical Trial Network (NCTN), NCI's Community Oncology Research Program (NCORP), and Experimental Therapeutics Clinical Trials Network (ETCTN). These programs’ will address cancer health disparities through a network of local multidisciplinary and integrated partners.

Without representative populations, especially in therapeutic trials, cancer disparities are likely to increase as all people may not be able to fully benefit from cutting-edge treatments and the promises of precision medicine. 

If you have any questions about the program, please email CP2CT@mail.nih.gov.

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Connecting Patient Populations to Clinical Trials (CP2CT) was originally published by the National Cancer Institute.”

Email